Paul Dorinsky Selected Research

Asthma (Bronchial Asthma)

1/2022	A randomized controlled trial of glycopyrrolate administered by metered dose inhaler in patients with uncontrolled asthma despite ICS/LABA treatment.
9/2018	Randomized dose-ranging study of a budesonide metered-dose inhaler by using co-suspension delivery technology in asthma.
1/2018	Efficacy, safety, and dose response of glycopyrronium administered by metered dose inhaler using co-suspension delivery technology in subjects with intermittent or mild-to-moderate persistent asthma: A randomized controlled trial.
12/2014	Impact of exhaled nitric oxide measurements on treatment decisions in an asthma specialty clinic.
7/2013	Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone.
1/2013	EGF-induced bronchial epithelial cells drive neutrophil chemotactic and anti-apoptotic activity in asthma.
9/2010	Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study.
10/2008	Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down".
5/2008	Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
1/2006	Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul Dorinsky Research Topics

Disease

29	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2018
21	Asthma (Bronchial Asthma) 01/2022 - 01/2002
6	Inflammation (Inflammations) 12/2014 - 01/2002
3	Respiratory Tract Infections (Respiratory Tract Infection) 10/2018 - 09/2010
2	Dyspnea (Shortness of Breath) 08/2021 - 01/2019
1	Lung Diseases (Lung Disease) 08/2021
1	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2021
1	Pneumonia (Pneumonitis) 01/2020
1	Nasopharyngitis 10/2018
1	Oral Candidiasis (Thrush) 01/2004

Drug/Important Bio-Agent (IBA)

20	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2004
16	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2022 - 01/2018
15	Budesonide (Pulmicort)FDA LinkGeneric 01/2022 - 01/2018
15	Formoterol Fumarate (Oxis)FDA Link 01/2022 - 01/2018
15	budesonide-glycopyrrolate-formoterol fumarate drug combinationIBA 10/2021 - 10/2018
12	SuspensionsIBA 01/2020 - 01/2018
12	Fluticasone (Cutivate)FDA LinkGeneric 07/2013 - 01/2002
9	Salmeterol Xinafoate (Serevent)FDA Link 01/2018 - 01/2002
9	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 10/2008 - 02/2002
6	Muscarinic AntagonistsIBA 10/2021 - 01/2018
5	apaflurane (hydrofluoroalkane)IBA 07/2013 - 09/2003
5	montelukast (Singulair)FDA Link 08/2005 - 01/2002
4	Albuterol (Salbutamol)FDA LinkGeneric 01/2006 - 02/2002
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 09/2010
2	2- n- butyl- 3- (dimethylamino)- 5,6- methylenedioxyindeneIBA 01/2019 - 01/2018
2	Beclomethasone (Beclometasone)FDA Link 07/2013 - 09/2010
2	norflurane (R 134a)IBA 01/2006 - 01/2004
1	Tiotropium Bromide (Spiriva)FDA Link 01/2022
1	GlucocorticoidsIBA 01/2020
1	N 30IBA 10/2018
1	AerosolsIBA 01/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2014
1	Epidermal Growth Factor (EGF)IBA 01/2013
1	Bronchodilator Agents (Bronchodilators)IBA 05/2008
1	Biomarkers (Surrogate Marker)IBA 05/2008
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 12/2004
1	zafirlukast (Accolate)FDA LinkGeneric 04/2002
1	LeukotrienesIBA 01/2002

Therapy/Procedure

32	Therapeutics 01/2022 - 01/2002
26	Metered Dose Inhalers (Metered Dose Inhaler) 01/2022 - 09/2003
3	Nebulizers and Vaporizers (Inhaler) 01/2021 - 01/2004
3	Dry Powder Inhalers 01/2020 - 01/2018
2	Drug Therapy (Chemotherapy) 12/2014 - 01/2006
1	Aftercare (After-Treatment) 01/2003